Ligand Pharmaceutical Inc (+N, LGND US, September 26th)
Todd Davis (CEO since 2022; Director since 2007) made his largest purchase, spending $238,000 on September 22nd at $59.38 and increasing his holdings by +4% to 73,090 shares. Davis has made two prior purchases, in August 2019 at $58 and in August 2011 at $7, both when he was a director, and both were timely.
His track record as a seller is even more impressive, and his last sale was in Feb. 2021 at $133. This is his first purchase since he took over as CEO in December 2022.
We are ranking the stock +N.
If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter
Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.
